Industry Ignited Podcast – Détails, épisodes et analyse

In this episode of Industry Ignited, host Dr. Leeanne Aguilar sits down with Lisa Voronkova, CEO of Ova Solutions and author of Hardware Bible: Build a Medical Device from Scratch, to unpack the real reasons medical devices fail, not in the lab, but in the real world.

Lisa shares hard-earned lessons from her own founder journey, including the classic trap of building around “cool tech” instead of solving a real clinical and commercial problem. Together, they explore what founders consistently underestimate: manufacturing realities, clinical adoption, reimbursement strategy and what truly happens after FDA clearance.

This conversation dives into why FDA approval is a milestone, not the finish line and how many startups get stuck in the “valley of death” between prototype and real revenue. Lisa explains the difference between building a prototype and designing for manufacturability, why hospital purchasing decisions are more complex than most founders realize, and how reimbursement can determine whether a breakthrough device ever reaches patients. They also discuss when outsourcing R&D makes sense, where AI is creating meaningful opportunity in medtech, and the single most important question every founder must answer before building anything: Who will pay and why?

𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐈𝐠𝐧𝐢𝐭𝐞𝐝 https://industryignited.com/
𝐈𝐧𝐬𝐭𝐚𝐠𝐫𝐚𝐦 https://www.instagram.com/industryignited/
𝐅𝐚𝐜𝐞𝐛𝐨𝐨𝐤 https://www.facebook.com/industryignited/
𝐋𝐢𝐧𝐤𝐞𝐝𝐈𝐧 https://www.linkedin.com/company/industry-ignited
𝐒𝐩𝐨𝐭𝐢𝐟𝐲 https://open.spotify.com/show/3TX1L5LPr4lt1UtcSpSvlN?si=7037433a58c54162
𝐀𝐩𝐩𝐥𝐞 𝐏𝐨𝐝𝐜𝐚𝐬𝐭 https://podcasts.apple.com/us/podcast/industry-ignited-podcast/id1824619671 

Lisa Voronkova
https://www.linkedin.com/in/lisa-voronkova/
https://www.linkedin.com/company/ova-solutions/

#podcasts #podcasts #podcastshorts #podcastinterview #podcastlife#businessgrowth #industryignited #drleeanneaguilar #lisavoronkova #innovation #medicine #medicaldevice

Hydrogen is often talked about as the fuel of the future, but what does it actually look like in practice?

In this episode of Industry Ignited, host Dr. Leeanne Aguilar sits down with Salim Rahemtulla, President and CEO of PowerTap Hydrogen Fuel Corp, to break down how hydrogen fuel cell vehicles work, where they make sense, and where they don’t. From 20-minute heavy-duty refueling to water-only tailpipe emissions, this conversation cuts through the noise and gets into real-world infrastructure, not science fiction.

Salim explains why hydrogen may not be the best solution for every vehicle, but could be transformative for long-haul trucking, transit buses, forklifts and industrial applications where downtime and payload matter. He also addresses safety concerns head-on, explaining how modern hydrogen storage and fueling systems are designed, regulated and deployed today.

𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐈𝐠𝐧𝐢𝐭𝐞𝐝 https://industryignited.com/
𝐈𝐧𝐬𝐭𝐚𝐠𝐫𝐚𝐦 https://www.instagram.com/industryignited/
𝐅𝐚𝐜𝐞𝐛𝐨𝐨𝐤 https://www.facebook.com/industryignited/
𝐋𝐢𝐧𝐤𝐞𝐝𝐈𝐧 https://www.linkedin.com/company/industry-ignited
𝐒𝐩𝐨𝐭𝐢𝐟𝐲 https://open.spotify.com/show/3TX1L5LPr4lt1UtcSpSvlN?si=7037433a58c54162
𝐀𝐩𝐩𝐥𝐞 𝐏𝐨𝐝𝐜𝐚𝐬𝐭 https://podcasts.apple.com/us/podcast/industry-ignited-podcast/id1824619671 

𝐒𝐚𝐥𝐢𝐦 𝐑𝐚𝐡𝐞𝐦𝐭𝐮𝐥𝐥𝐚
https://www.linkedin.com/in/salimrahemtulla/
https://www.linkedin.com/company/powertap-hydrogen-fueling-corp/

#podcasts #podcasts #podcastshorts #podcastinterview #podcastlife#businessgrowth #industryignited #drleeanneaguilar #salimrahemtulla #innovation 

In this episode of Industry Ignited, host Dr. Leeanne Aguilar interviews Robert Poe, President and CEO of Olon USA, about what it takes to move a fragile lab concept into a real-world, life-changing medicine—at scale, safely, and with quality. Robert shares his unconventional leadership journey (from combat medic and lab maintenance to CEO), the power of mentors who allow people to learn through failure, and why decisive leadership beats “paralysis by analysis” in high-stakes environments. He demystifies Olon USA’s role in pharmaceutical development—helping clients develop and manufacture the API (active pharmaceutical ingredient) and scale programs from early-stage molecules through clinical phases and commercialization—while highlighting the brutal reality of drug development’s high failure rate and the importance of resilience, partnership, and scientific rigor. Great pharma manufacturing leadership is people-centered and mission-driven—building trust, closing feedback loops, and acting as a true problem-solving partner so promising therapies can reach patients and strengthen the U.S. drug supply chain.

In this episode of Industry Ignited, host Dr. Leeanne Aguilar sits down with Angie Griffin, Chief Commercial Officer at Third Coast, to unpack what it really takes to scale a fast-growing chemical company without losing agility, safety, or customer intimacy. Angie shares her unconventional path from English degrees to commercial leadership, then breaks down Third Coast’s core growth challenge—when revenue and demand outpace processes—and how the team redesigned critical workflows like order-to-cash by involving the people closest to the work, not just leadership. The key takeaway: sustainable growth isn’t about slowing down—it’s about building the “engine” mid-flight through empowered teams, practical process improvement, and clear operational guardrails that keep a nimble culture intact while scaling for the next decade.

In this Industry Ignited episode, Dr. Leeanne Aguilar interviews Robert Swint, CEO of ATA Associates, whose 50-year career spans NASA’s Apollo and Space Shuttle programs to some of the world’s most complex accident and failure investigations. Drawing on his 24 years at NASA—including work on Apollo, Apollo 13 recovery, Shuttle avionics integration, and space-station safety—Bob explains how systems thinking, human factors, and rigorous data analysis are the foundation of both spaceflight safety and modern forensic engineering. Catastrophic failures rarely come from a single mistake; they emerge when systems, technology, and human decisions interact—and the only path to truth and prevention is disciplined, objective analysis grounded in science, data, and transparency. From Exxon Valdez and Deepwater Horizon to trucking, marine, aviation, and petrochemical cases, Bob reveals how evolving technologies like instrumentation, 3D scanning, and emerging AI are transforming accident reconstruction from educated guesswork into fact-based accountability that ultimately saves lives.

In this Industry Ignited episode, Dr. Leeanne Aguilar sits down with Tim Mikhelashvili, CEO and Co-Founder of Amedea Pharma, to explore how life sciences can achieve elite performance by borrowing principles from Olympic sports and data science. Drawing on more than 20 years across pharma, biotech, and medical affairs, Tim shares how early exposure to drug recalls and poor manufacturing conditions shaped his mission to raise healthcare quality standards, why traditional metrics fail to drive real accountability, and how organizations can connect purpose, progress, and reward through transparent performance systems. Healthcare organizations don’t need more pressure—they need better accountability models that measure both results and behaviors, empowering teams to operate like championship athletes while improving patient outcomes. From launching the ANCORA platform to hosting the Medical Innovation Olympics, Tim offers a compelling blueprint for turning accountability into motivation and scaling excellence across the life sciences industry.

In this Industry Ignited episode, Dr. Leeanne Aguilar talks with Andrew Bish, CEO of BISH Enterprises and Hemp Harvest Works (Giltner, Nebraska) and President of the Hemp Feed Coalition, about what it takes to modernize agriculture when the barriers aren’t just engineering—they’re markets, policy, and perception. Andrew shares how returning to his small-town roots shaped his leadership, how corporate lessons (including what not to do) influenced his long-term approach, and why he’s drawn to “weird problems” in niche crops where real innovation still exists. Hemp’s future in American farming depends on building an entire system—machines that harvest it efficiently, supply chains that make it profitable, and FDA/AAFCO approvals that normalize it as safe animal feed. From designing equipment that boosts combine efficiency to pushing science-based evidence that THC transfer fears are unfounded, Andrew paints a practical vision of hemp as a third rotational commodity that can improve soil health, reduce chemical dependence, stabilize farm income, and accelerate regenerative agriculture—if regulation catches up to reality.

In this Industry Ignited episode, Dr. Leeanne Aguilar sits down with Chandan Manocha, CEO of Player Footwear Company in Delhi, India, to explore how a third-generation manufacturer can be modernized through science, design thinking, and customer-first innovation. Taking over the business at just 19 during COVID, Chandan used the shutdown as a reset moment—revamping operations, shifting from traditional closed footwear into open footwear better suited to India’s hot, humid climate, and helping brands ride the post-COVID surge in fashionable sandals and slip-ons. Chandan explains how great footwear isn’t just style—it’s applied science. By designing from first principles, consulting doctors, conducting gait analysis, and discovering how common foot deformities and flat feet really are, Chandan built a process focused on comfort, posture, and “one product fits most,” while also evolving materials through gradual upcycling and higher natural-content blends. From wider Indian sizing needs to the emerging role of 3D printing and AI, this conversation highlights what it takes to shift culture, upgrade legacy manufacturing, and position Player Footwear for a future global breakthrough design.

In this Industry Ignited episode, Dr. Leeanne Aguilar interviews Richard Rives Bird, President of Rives Consult, on why breakthrough medical devices don’t succeed on innovation alone—they succeed when founders pair great science with the right commercialization strategy, regulatory pathway, and reimbursement reality. Richard shares how he moved from physics into clinical affairs after a CEO recognized his ability to work with clinicians, and why he pioneered a fractional executive model (before it was mainstream) to give early-stage startups—especially European innovators entering the U.S.—hands-on expertise without the cost of full-time leadership. The conversation delivers a clear, practical takeaway: start with customer discovery and economics (follow the money), define reimbursement and workflow impact early, launch with an MVP and a focused indication for use, and build traction through real sales process learning before handing it to distributors—a playbook Richard uses to “graduate” clients into scalable growth. From FDA pre-subs and faster U.S. timelines versus EU MDR delays to inspiring examples like triple-negative breast cancer monitoring and regenerative medicine scaffolds, this episode is a masterclass in turning life science innovation into market impact.

In this episode of Industry Ignited, Dr. Leeanne Aguilar sits down with Sol Bobst, President of Solar Ranch Development Company and ToxSci Advisors, to explore how Texas can meet a rapidly accelerating power demand through practical, scalable renewable energy development. Sol shares how his background as a board-certified toxicologist and applied scientist led him from oil and gas into solar entrepreneurship, and why his core strategy—partnering with Texas landowners to develop distributed solar-plus-storage projects—is designed to bring power online faster than many large projects that stall in the ERCOT pipeline. From agrivoltaics (like sheep grazing and honey bees) to grid-tied battery storage that strengthens reliability during extreme heat and winter storms, the conversation highlights how a distributed, smarter grid can protect rural land legacies, improve affordability, and keep the lights on as Texas load forecasts surge—making the episode a must-listen for energy investors, landowners, and anyone tracking the future of solar and storage in ERCOT.